Inventor · disambiguated record
Naoko Yamane
Also filed as: YAMANE NAOKO
28 granted patents·9 pending applications·1,586 citations·filing 2001–2019
98Inventor score
Technology areasA61P
Top patents by PatentIndex Score
37 records- 0199US7214775B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KOGYO KK·Filed 2005·Granted May 8, 2007·363 cites·7 claims
- 0298US7737325B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Jun 15, 2010·55 cites·14 claims
- 0398US7708992B2Methods for producing antibody compositions with increased ADCCKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted May 4, 2010·51 cites·16 claims
- 0498US7651688B2Method of modulating the activity of functional immune molecules to CD52KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Jan 26, 2010·47 cites·3 claims
- 0598US7425446B2Antibody composition-producing cellKYOWA HAKKO KOGYO KK·Filed 2005·Granted Sep 16, 2008·93 cites·6 claims
- 0698US7393683B2Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferaseKYOWA HAKKO KOGYO KK·Filed 2005·Granted Jul 1, 2008·63 cites·6 claims
- 0798US6946292B2Cells producing antibody compositions with increased antibody dependent cytotoxic activityKYOWA HAKKO KOGYO KK·Filed 2001·Granted Sep 20, 2005·566 cites·12 claims
- 0897US8067232B2Antibody composition-producing cell with inactivated A-1,6-fusocyltransferaseKANDA YUTAKA·Filed 2008·Granted Nov 29, 2011·45 cites·5 claims
- 0997US7846725B2Antibody composition-producing cell in which enzyme expression is inhibited by RNAiKYOWA HAKKO KIRIN CO LTD·Filed 2008·Granted Dec 7, 2010·35 cites·6 claims
- 1097US7741442B2Antibody composition exhibiting increased cellular cytotoxicity due to glycosylationKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Jun 22, 2010·32 cites·4 claims
- 1197US7718175B2Method of modulating the activity of functional immune molecules to interleukin-5 receptor proteinKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted May 18, 2010·32 cites·3 claims
- 1297US7687061B2Method of modulating the activity of functional immune molecules to Her-2KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 30, 2010·29 cites·3 claims
- 1397US7682610B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 23, 2010·33 cites·3 claims
- 1496US7763246B2Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptorKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Jul 27, 2010·23 cites·3 claims
- 1596US7708997B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted May 4, 2010·24 cites·3 claims
- 1696US7682611B2Method of modulating the activity of functional immune molecules to CXCR4 proteinKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 23, 2010·26 cites·3 claims
- 1796US7655228B2Method of modulating the activity of functional immune molecules to GM2KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Feb 2, 2010·24 cites·3 claims
- 1892US8039595B2Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylationKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted Oct 18, 2011·9 cites·5 claims
- 1990US8679491B2Method of modulating the activity of functional immune moleculesHANAI NOBUO·Filed 2009·Granted Mar 25, 2014·12 cites·2 claims
- 2089US8101185B2Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylationKANDA YUTAKA·Filed 2010·Granted Jan 24, 2012·6 cites·4 claims
- 2187US8895266B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2012·Granted Nov 25, 2014·4 cites·4 claims
- 2287US8158760B2Glycoengineered, recombinant antibodyKANDA YUTAKA·Filed 2009·Granted Apr 17, 2012·4 cites·4 claims
- 2386US8329443B2Antibody composition-producing cellKANDA YUTAKA·Filed 2011·Granted Dec 11, 2012·4 cites·4 claims
- 2486US8110195B2Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibodyKANDA YUTAKA·Filed 2010·Granted Feb 7, 2012·4 cites·4 claims
- 2583US10233247B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Mar 19, 2019·2 cites·6 claims
- 2674US2019360015A1Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2019·Application pending·0 cites
- 2774US2010143388A1Antibody Composition-Producing CellKYOWA HAKKO KIRIN CO LTD·Filed 2009·Application pending·0 cites
- 2874US2020017593A1Method of producing antibodies with n-glycoside-linked sugar chains lacking fucosylationKYOWA HAKKO KIRIN CO LTD·Filed 2019·Application pending·0 cites
- 2973US8367407B2Cells with altered fucosylation and producing antibodies therefromKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted Feb 5, 2013·0 cites·14 claims
- 3072US9409982B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Aug 9, 2016·0 cites·7 claims
- 3168US10233475B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2016·Granted Mar 19, 2019·0 cites·20 claims
- 3267US2017240647A1Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2017·Application pending·0 cites
- 3364US2007010009A1Antibody Composition-Producing CellKYOWA HAKKO KOGYO KK·Filed 2006·Application pending·0 cites
- 3463US2006064781A1Antibody composition-producing cellKYOWA HAKKO KOGYO KK·Filed 2005·Application pending·0 cites
- 3561US2011027271A1Antibody composition exhibiting cellular cytotoxicty due to glycosylationKYOWA HAKKO KIRIN CO LTD·Filed 2010·Application pending·0 cites
- 3650US2005216958A1Cells of which genome is modifiedKYOWA HAKKO KOGYO KK·Filed 2005·Application pending·0 cites
- 3750US2004110704A1Cells of which genome is modifiedKYOWA HAKKO KOGYO KK·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Naoko Yamane files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →